✦ LIBER ✦

Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale

✍ Scribed by Charles J. Ryan; Amy M. Lin; Eric J. Small

Book ID: 116955885
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 95 KB
Volume: 24
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2005.11.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy for the treatment of hormon

Chemotherapy for the treatment of hormone-refractory prostate cancer

✍ S. Chowdhury; S. Burbridge; P. G. Harper 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Chemotherapy for hormone-refractory pros

Chemotherapy for hormone-refractory prostate cancer: a physician's dilemma

✍ N. Tageja 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Three Weekly Docetaxel plus Predinsolone

Three Weekly Docetaxel plus Predinsolone for Patients with Hormone-Refractory Metastatic Prostate Cancer: Preliminary Result

✍ Abd El Halim M. Abu-Hamar; Saleh Mansour; Mohamed M. El Shebiney; Naser M. Abd E 📂 Article 📅 2010 🏛 Dougmar Publishing Group, Inc. 🌐 English ⚖ 89 KB

Combination chemotherapy with docetaxel,

Combination chemotherapy with docetaxel, estramustine and suramin for hormone refractory prostate cancer

✍ Mohammad Reza Safarinejad 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Combination Chemotherapy with Paclitaxel

Combination Chemotherapy with Paclitaxel, Estramustine and Carboplatin for Hormone Refractory Prostate Cancer

✍ URAKAMI, SHINJI; IGAWA, MIKIO; KIKUNO, NOBUYUKI; YOSHINO, TATEKI; KISHI, HIROFUM 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 90 KB

708 INTERMITTENT CHEMOTHERAPY FOR METAST

708 INTERMITTENT CHEMOTHERAPY FOR METASTATIC HORMONE REFRACTORY PROSTATE CANCER: LONG TERM RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL

✍ Ozen, Haluk; Akdogan, Bulent; Ergen, Ali; Gunay, Levent Mert; Kirdal, Yeter; Inc 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 46 KB